// App-Quantinova.ai

1636 : Long-term Renal Survival of Patients with LN by Renal Response Status in the Toronto Lupus Cohort

Researchers

Presenter

  • Murray Urowitz

Principal Investigators

  • Mary E. Georgiou

  • Jiandong Su

  • Anne MacKinnon

  • Yulia Green

  • Kerry Gairy

  • Roger A Levy

  • Patricia C. Juliao

Medical Centers

  • University of Toronto, University Health Network, Schroeder Arthritis Institute, Toronto, ON, Canada

  • GlaxoSmithKline, Value Evidence and Outcomes, Brentford, United Kingdom

  • University of Toronto Lupus Program, Schroeder Arthritis Institute, University Health Network, Division of Rheumatology, Toronto, ON, Canada

  • GlaxoSmithKline, Clinical Development, Brentford, Middlesex, United Kingdom

  • GlaxoSmithKline, Global Medical Affairs, Collegeville, PA

  • GlaxoSmithKline, Value Evidence and Outcomes, Collegeville, USA

Locations

  • Turkmenistan

  • Canada

  • United Kingdom

  • United States

Companies

  • N/A

Study Components

Therapeutic Area

  • Nephrology

  • Autoimmune (AI)

  • Endocrine/metabolic Diseases (ME)

Disease

  • Chronic kidney disease

  • Albuminuria

  • Lupus

Biomarkers

  • N/A

Drug/Treatment

  • N/A

Outcome

  • N/A

Study Design

  • Observational

  • Cohort

Phase

  • N/A

Study Id's

  • NCT01639339

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved